Evidence map›Paper›PMID 28269755›Full record

ArticleCancer biomarkers : section A of Disease markers2017

MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.

Qiuyue Yuan, Tingge Sun, Feng Ye, Weisheng Kong, Haofan Jin

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in oncology · 2020
    Article
  14. The role of Aurora-A in human cancers and future therapeutics.American journal of cancer research · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Qiuyue YuanCancer Cente, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Tingge SunCancer Cente, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Feng YeCancer Cente, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Weisheng KongBASO Cell Science and Technology Co., Ltd., Zhuhai, Guangdong 519015, China.
Haofan JinCancer Cente, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Jilin University · CNCell Technology (China) · CNFirst Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to establish the relationship between miR-124-3p and Aurora A kinase (AURKA) in bladder cancer (BC).

methodsThe expressions of miR-124-3p and AURKA in BC tissues and cell lines were detected using RT-PCR and western blot. BC cells were transfected with miR-124-3p mimics and AURKA siRNA. After this cell proliferation, migration, cell cycle and apoptosis were measured using CCK-8, colony formation assay, wound healing assay and cytometry tests. The relationship between miR-124-3p and AURKA was confirmed with luciferase reporter assay. Mice xenograft models were constructed to examine the effects of AURKA on BC in vivo.

resultsMiR-124-3p expression was significantly down-regulated in BC tissues and cell lines, while AURKA was significantly up-regulated compared to normal samples. MiR-124-3p targeted AURKA and decreased its expression. Transfection of miR-124-3p mimics and AURKA siRNA was shown to down-regulate BC cell proliferation and migration as well as induce cell apoptosis. As suggested by xenograft models, the inhibition of AURKA can effectively suppress tumor growth.

conclusionMiR-124-3p has significant impact on proliferation, migration and apoptosis of BC cells by targeting AURKA.

Indexed as

AnimalsApoptosisAurora Kinase ABiomarkers, TumorCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMaleMiceMicroRNAsUrinary Bladder NeoplasmsXenograft Model Antitumor AssaysAURKA protein, humanAurora Kinase ABiomarkers, TumorMicroRNAsMIRN124 microRNA, humanAURKAbladder cancerMicroRNA-124-3p

Identifiers

PMID28269755
PMCPMC13020699
OpenAlexW2592950838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.